Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone
Authors:
- N. ZamberlanNZN. Zamberlan
- M. MianMMM. Mian
- R. DorizziRDR. Dorizzi
- M. RossiniMRM. Rossini
- B. BragaBBB. Braga
- D. GattiDGD. Gatti
- F. BertoldoFBF. Bertoldo
- V. LocascioVLV. Locascio
- 1 May 1994
- journal article
- Published by Elsevier in Bone and Mineral
- Vol. 25 (2) , 75-82
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effects of five daily 1 h infusions of alendronate in paget's disease of boneJournal of Bone and Mineral Research, 1992
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Journal of Clinical Investigation, 1991
- BisphosphonatesDrugs, 1991
- Effect of a Single Infusion of Aminohydroxypropylidene on Calcium and Bone Metabolism in Healthy Volunteers Monitored during 2 MonthsThe Journal of Clinical Endocrinology & Metabolism, 1991
- Treatment of paget's disease of bone with aminohydroxybutylidene bisphosphonateJournal of Bone and Mineral Research, 1990
- TREATMENT OF PAGET'S DISEASE OF BONEClinical Endocrinology, 1990
- A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of boneThe American Journal of Medicine, 1988
- Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the ratCalcified Tissue International, 1986
- Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonateCalcified Tissue International, 1986
- Regulation of calcium absorption by 1,25,dihydroxy-vitamin D—Studies of the effects of a bisphosphonate treatmentCalcified Tissue International, 1982